Pharmacology

Action Mechanism of Action Reference
AGONIST Erythropoietin receptor agonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Kidney Failure, Chronic 4 D007676 ClinicalTrials
Kidney Failure, Chronic 4 D007676 ClinicalTrials
Prostatic Neoplasms 3 D011471 ClinicalTrials
Hepatitis C 3 D006526 ClinicalTrials
Head and Neck Neoplasms 3 D006258 ClinicalTrials
Venous Thrombosis 3 D020246 ClinicalTrials
Heart Arrest 3 D006323 ClinicalTrials
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Leukemia 3 D007938 ClinicalTrials
Fatigue 3 D005221 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Lung Neoplasms 3 D008175 ClinicalTrials
Brain Injuries 3 D001930 ClinicalTrials
Peritoneal Neoplasms 3 D010534 ClinicalTrials
Ovarian Neoplasms 3 D010051 ClinicalTrials
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Hypoxia-Ischemia, Brain 3 D020925 ClinicalTrials
Leukemia, Myeloid, Acute 3 D015470 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Peripheral Nervous System Diseases 2 D010523 ClinicalTrials
Stroke 2 D020521 ClinicalTrials
Anemia, Neonatal 2 D000751 ClinicalTrials
Friedreich Ataxia 2 D005621 ClinicalTrials
Myocardial Infarction 2 D009203 ClinicalTrials
Coronary Disease 2 D003327 ClinicalTrials
Premature Birth 2 D047928 ClinicalTrials
beta-Thalassemia 2 D017086 ClinicalTrials
ST Elevation Myocardial Infarction 2 D000072657 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Substance-Related Disorders 1 D019966 ClinicalTrials
Diabetic Foot 1 D017719 ClinicalTrials
Asphyxia 1 D001237 ClinicalTrials
Anemia, Sickle Cell 1 D000755 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1201565
FDA SRS 64FS3BFH5W